Join our panel discussion- Wed 23rd @ 16.40
Biologically relevant information- improving success of clinical trials!
Panelists:
Dr Teodor Aastrup, CEO,
Attana
Dr Juan Carlos Almagro, Research Fellow, Head, Antibody Design Unit,
Centocor
Dr Jesus Zurdo, Head of Innovation LCM Development Services,
Lonza
Dr Alain Beck, Head of Physico Chemistry,
Centre d'Immunologie Pierre Fabre
The panel discussion will be introduced with a presentation by Dr Jesus Zurdo, Head of Innovation LCM Development Services with Lonza on Managing development risks in biopharmaceuticals through lead optimisation and early analytical tools at 16.20.
The
AED Conference is dedicated to accelerating the development of therapeutic antibodies through engineering approaches.